Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05514912
Title	Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial
Recruitment	Withdrawn
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Emory University
Indications	intrahepatic cholangiocarcinoma
Therapies	Cisplatin + Gemcitabine + Nab-paclitaxel Cisplatin + Gemcitabine + Infigratinib + Nab-paclitaxel
Age Groups:	senior \| adult
Covered Countries